Conclusion The study elucidates the distinct metabolic remodeling in GDHS patients, identifying a panel of biomarkers with strong diagnostic potentialincluding serum IDAB, L2FC, TPTG, LDPL, L6TG, L3CH, glycine, citric acid, lactic acid, and succinic acid, as well as urinary phenylpyruvic acid and glycine
Hydropersulfides are endogenous antioxidants that inhibit ferroptosis
Thus, the protein appears to have a partially functional glutathione-scaffold site
Concomitant medicines : Clinicians should review all concurrent medications, particularly insulin or sulfonylureas, given the potential for hypoglycaemia with incretin-based agents
563 Monitoring and considerations include dose titration, initiating medications at low doses and gradually increasing to the maximum tolerated dose while monitoring efficacy and adverse effects